Dangheng Wei

2.4k total citations
50 papers, 2.0k citations indexed

About

Dangheng Wei is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Dangheng Wei has authored 50 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 16 papers in Epidemiology and 14 papers in Immunology. Recurrent topics in Dangheng Wei's work include Autophagy in Disease and Therapy (12 papers), Atherosclerosis and Cardiovascular Diseases (10 papers) and Inflammasome and immune disorders (7 papers). Dangheng Wei is often cited by papers focused on Autophagy in Disease and Therapy (12 papers), Atherosclerosis and Cardiovascular Diseases (10 papers) and Inflammasome and immune disorders (7 papers). Dangheng Wei collaborates with scholars based in China, Canada and United Kingdom. Dangheng Wei's co-authors include Zhong Ren, Wang Zuo, Lushan Liu, Zhi‐Sheng Jiang, Juan Peng, Zhi‐Han Tang, Peng Wu, Jiaojiao Chen, Xi‐Long Zheng and Zhi-Han Tang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Free Radical Biology and Medicine and American Journal Of Pathology.

In The Last Decade

Dangheng Wei

50 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dangheng Wei China 24 926 559 526 380 336 50 2.0k
Zhi‐Sheng Jiang China 28 972 1.0× 545 1.0× 867 1.6× 396 1.0× 361 1.1× 63 2.5k
Jenny E. Kanter United States 22 581 0.6× 434 0.8× 321 0.6× 319 0.8× 218 0.6× 42 1.5k
Maaike Kockx Australia 25 1.1k 1.2× 259 0.5× 876 1.7× 335 0.9× 370 1.1× 60 2.3k
Amy S. Major United States 27 857 0.9× 1.3k 2.4× 750 1.4× 453 1.2× 290 0.9× 57 2.7k
Alan C. Wagner United States 21 604 0.7× 445 0.8× 937 1.8× 283 0.7× 383 1.1× 23 2.1k
Rebecca Schuster United States 29 1.1k 1.2× 594 1.1× 526 1.0× 486 1.3× 296 0.9× 84 2.5k
Takafumi Senokuchi Japan 23 825 0.9× 385 0.7× 441 0.8× 365 1.0× 212 0.6× 42 1.7k
Daiji Kawanami Japan 28 1.2k 1.3× 345 0.6× 340 0.6× 532 1.4× 323 1.0× 81 2.7k
Yaxi Chen China 18 867 0.9× 290 0.5× 283 0.5× 565 1.5× 544 1.6× 50 1.9k
Christine Lohmann Switzerland 23 555 0.6× 604 1.1× 359 0.7× 353 0.9× 174 0.5× 32 2.0k

Countries citing papers authored by Dangheng Wei

Since Specialization
Citations

This map shows the geographic impact of Dangheng Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dangheng Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dangheng Wei more than expected).

Fields of papers citing papers by Dangheng Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dangheng Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dangheng Wei. The network helps show where Dangheng Wei may publish in the future.

Co-authorship network of co-authors of Dangheng Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Dangheng Wei. A scholar is included among the top collaborators of Dangheng Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dangheng Wei. Dangheng Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yue, et al.. (2025). Targeting Immune Cell Metabolism: A Promising Therapeutic Approach for Cardiovascular Disease. Immunology. 175(2). 134–150. 1 indexed citations
2.
3.
Lü, Li, et al.. (2022). Succinate: A Novel Mediator to Promote Atherosclerotic Lesion Progression. DNA and Cell Biology. 41(3). 285–291. 19 indexed citations
4.
Lü, Li, et al.. (2022). Mitophagy: Critical Role in Atherosclerosis Progression. DNA and Cell Biology. 41(10). 851–860. 13 indexed citations
5.
Li, Lu, et al.. (2021). Research Progress on the Role of Intermediate Filament Vimentin in Atherosclerosis. DNA and Cell Biology. 40(12). 1495–1502. 2 indexed citations
6.
Chen, Jiaojiao, Jun Tao, Xiaolei Zhang, et al.. (2020). Inhibition of the ox-LDL-Induced Pyroptosis by FGF21 of Human Umbilical Vein Endothelial Cells Through the TET2-UQCRC1-ROS Pathway. DNA and Cell Biology. 39(4). 661–670. 31 indexed citations
7.
Zhang, Jianwu, et al.. (2020). Low shear stress induced vascular endothelial cell pyroptosis by TET2/SDHB/ROS pathway. Free Radical Biology and Medicine. 162. 582–591. 51 indexed citations
8.
Luo, Wen, Zhong Ren, Lijun Peng, et al.. (2020). Hydrogen Sulfide Switch Phenomenon Regulating Autophagy in Cardiovascular Diseases. Cardiovascular Drugs and Therapy. 34(1). 113–121. 29 indexed citations
9.
Wu, Shiyuan, et al.. (2019). Essential Role of Nonessential Amino Acid Glutamine in Atherosclerotic Cardiovascular Disease. DNA and Cell Biology. 39(1). 8–15. 28 indexed citations
10.
Peng, Wen, Kai Qu, Xiaolong Lin, et al.. (2018). TET2 : A Novel Epigenetic Regulator and Potential Intervention Target for Atherosclerosis. DNA and Cell Biology. 37(6). 517–523. 44 indexed citations
11.
Zeng, Zhaolin, Kai Zhang, Yue Zhao, et al.. (2017). miR‐23b‐3p and miR‐125b‐5p downregulate apo(a) expression by targeting Ets1 in HepG2 cells. Cell Biology International. 42(3). 313–323. 13 indexed citations
12.
Xia, Xiao-Dan, et al.. (2017). Endothelial-to-Mesenchymal Transition: A Potential Mechanism for Atherosclerosis Plaque Progression and Destabilization. DNA and Cell Biology. 36(11). 883–891. 22 indexed citations
13.
Tang, Zhi‐Han, Juan Peng, Zhong Ren, et al.. (2017). New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway. Atherosclerosis. 262. 113–122. 222 indexed citations
14.
Li, Tingting, Juan Peng, Bei He, et al.. (2017). TM6SF2: A novel target for plasma lipid regulation. Atherosclerosis. 268. 170–176. 31 indexed citations
15.
Li, Guohua, Xiaolong Lin, Hai Zhang, et al.. (2015). Ox-Lp(a) transiently induces HUVEC autophagy via an ROS-dependent PAPR-1-LKB1–AMPK–mTOR pathway. Atherosclerosis. 243(1). 223–235. 34 indexed citations
16.
Kuang, Peng, Lu-Shan Liu, Dangheng Wei, et al.. (2015). P2X7R is involved in the progression of atherosclerosis by promoting NLRP3 inflammasome activation. International Journal of Molecular Medicine. 35(5). 1179–1188. 110 indexed citations
17.
Tang, Zhi‐Han, Zhong Ren, Xing Liu, et al.. (2013). Hydrogen sulfide prevents H2O2-induced senescence in human umbilical vein endothelial cells through SIRT1 activation. Molecular Medicine Reports. 7(6). 1865–1870. 76 indexed citations
18.
Wei, Dangheng, Robert Guidoin, Г. Маринов, et al.. (2013). Absence of Tissue Ingrowth through the Textile Fabric in a Series of Explanted Clinic Stent-Grafts. Journal of Long-Term Effects of Medical Implants. 23(4). 339–357. 1 indexed citations
19.
Wei, Dangheng, Xiaoying Jia, Yang‐hui Liu, et al.. (2012). Cathepsin L stimulates autophagy and inhibits apoptosis of ox-LDL-induced endothelial cells: Potential role in atherosclerosis. International Journal of Molecular Medicine. 31(2). 400–406. 38 indexed citations
20.
Tang, Chao‐Ke, HE Xiu-sheng, Guanghui Yi, et al.. (2003). The action of liver X receptor #alpha# on cholesterol efflux in THP-1 macrophage-derived foam cells. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS. 30(6). 940–944. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhi‐Sheng Jiang Breakdown of academic impact, for papers by Jenny E. Kanter Breakdown of academic impact, for papers by Maaike Kockx Breakdown of academic impact, for papers by Amy S. Major Breakdown of academic impact, for papers by Alan C. Wagner Breakdown of academic impact, for papers by Rebecca Schuster Breakdown of academic impact, for papers by Takafumi Senokuchi Breakdown of academic impact, for papers by Daiji Kawanami Breakdown of academic impact, for papers by Yaxi Chen Breakdown of academic impact, for papers by Christine Lohmann
Rankless by CCL
2026